Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
18,079 total articles
Spotify announced that it paid out more than $11 billion to the music industry in 2025, marking the largest annual payment from a retailer on record. Payouts increased by over 10% from the prior year, with independent artists and labels accounting for 50% of royalties. The company highlighted its payout formula and said it is reinvesting retained r…
Spotify disclosed that it paid out more than $11 billion to the music industry in 2025, the largest annual payment from a retailer to the music business on record. Payouts rose by over 10% versus 2024, with independent artists and labels receiving half of all royalties. The company says it returns roughly two-thirds of music revenue to rights holde…
Insider disclosures filed late this month reveal sizable stock purchases at Mirum Pharmaceuticals, Hycroft Mining and Intel, while senior executives at Goldman Sachs, AutoZone, Northern Trust and Wayfair reported multimillion-dollar sales. The filings span transactions executed between January 23 and January 26, 2026, and include option exercises, …
Altimmune Inc. disclosed a $75 million registered direct offering of common stock to a new institutional investor, a move that coincided with a roughly 6.2% decline in premarket trading. Proceeds are earmarked to support preparation for a Phase 3 trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH) and for general corpora…
GRI Bio Inc reported additional RNA-sequencing evidence from its Phase 2a trial of GRI-0621 in idiopathic pulmonary fibrosis (IPF) showing significant changes in genes tied to lung injury, myofibroblast activation, and fibrosis progression versus placebo. The company says the pattern of gene expression supports mechanisms consistent with fibrosis r…
Immix Biopharma's stock climbed 5% after the U.S. Food and Drug Administration awarded Breakthrough Therapy Designation to NXC-201 for relapsed/refractory AL Amyloidosis. The decision was based on interim results from the NEXICART-2 Phase 2 trial presented at the American Society of Hematology meeting in December 2025. The company plans to complete…
Itron said it is deepening its strategic collaboration with Microsoft by introducing an Itron Intelligent Edge Operating System (IEOS) Connector for Microsoft 365 Copilot, enabling utilities to query operational data with natural language. The announcement, which also includes plans to offer Itron solutions through the Microsoft Marketplace and to …
Morgan Stanley upgraded Johnson & Johnson to Overweight from Equal weight and increased its price target to $262 from $200, citing accelerating commercial momentum from a slate of recent and forthcoming drug launches. The bank now forecasts earnings that are about 20% above consensus on aggregate and expects revenue and earnings to grow faster than…
Circle Internet Group shares rose after Mizuho upgraded the stock from Underperform to Neutral, citing robust USDC usage on prediction market Polymarket. The analyst raised USDC circulation forecasts for 2026/27, though his estimates remain below consensus, and flagged potential upside to USDC market capitalization tied to Polymarket volumes.
BIO-Key International's stock rose sharply in premarket trading after the company announced a strategic partnership with Portuguese systems integrator Visualforma to deploy its identity and access management and biometric authentication solutions across Portugal's public sector, including municipal administrations, schools and healthcare providers.
Ondas Holdings Inc. (NASDAQ:ONDS) shares rose 2% after the company said its American Robotics Optimus drone was added to the Defense Contract Management Agency Blue UAS Cleared List. The designation affirms the platform meets Department of War standards for cybersecurity, supply-chain integrity, and operational reliability and makes the system elig…
Beamr Imaging Ltd. (NASDAQ: BMR) saw its shares rise 2% in premarket trade as the video optimization firm prepares to present a three-layer validation framework at Mile High Video 2026 in Denver. The system combines a real-time AI upscaler, a patented Content-Adaptive Bitrate tool, and a human-aligned quality verification layer to help broadcasters…
Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) saw its shares jump 150.5% in premarket trading following disclosure of a non-binding Memorandum of Understanding with SwiftStart Inc. for a proposed $80 million equity investment at $1.50 per share. The MOU contemplates collaboration on digital transformation, risk management systems, data asset operations …
UK blue chips fell on Wednesday as investors processed corporate earnings and guidance updates. The FTSE 100 dipped 0.5% while the pound eased 0.4% to 1.3786 against the dollar. Broader European markets were lower, led by luxury names after LVMH signalled caution despite modest quarterly sales growth. A range of UK-listed companies from retail to m…
AeroVironment's UES division won a $75 million, five-year task order from the U.S. Air Force under the Functional Responsive Experimentation for Systems and Humans (FRESH) program. The work will focus on advanced polymers, responsive materials, biomanufacturing and biologically driven techniques for material degradation and rare earth extraction, w…
Autozi surged in premarket trading after its founder and controlling shareholder, Dr. Zhang Houqi, said he would use between $10 million and $30 million of personal funds to buy company shares at $5 each over the next 12 months. The commitment is presented as support for Autozi’s three-year strategic plan, which targets profitability, domestic expa…
Sleep Number shares rose after Kansas City Chiefs tight end Travis Kelce agreed to a multi-year partnership that includes an equity stake of under 5% and national advertising commitments. Kelce will buy shares directly and receive restricted stock that vests over three years; the company did not disclose the exact value of his holding.
Kepler Cheuvreux has downgraded Boliden to Hold from Buy ahead of the miner's fourth-quarter results, citing constrained upside after a significant share-price rally even as the broker raised its target price to SEK 640. The analyst lifted metal price assumptions and pushed up earnings estimates, while forecasting Q4 2025 EBIT excluding process inv…
REGENXBIO Inc. shares dropped 28% Wednesday after U.S. regulators placed clinical holds on two of the biotech's investigational gene therapies for ultra-rare pediatric disorders. The action stems from the identification of a brain tumor in a child treated with RGX-111 four years earlier; preliminary analysis found an AAV vector genome integration e…
In a UK Equity Research note, Stifel identifies a focused group of energy stocks it believes are well placed to manage market dynamics heading into 2026. The broker emphasizes companies with resilient production profiles, disciplined capital allocation and the ability to generate substantial free cash flow, singling out Afentra Plc, Valeura Energy,…
Mizuho upgraded Applied Materials to Outperform from Neutral and raised its price target to $370 from $275, citing a sharp rebound in wafer fab equipment (WFE) spending and stronger demand from foundry and logic customers. The firm now projects WFE growth of 13% year-over-year in 2026 and 12% in 2027, and points to higher TSMC capex and improving I…
CalciMedica Inc. (NASDAQ:CALC) saw its stock fall roughly 80% on Wednesday after an Independent Data Monitoring Committee recommended stopping the Phase 2 KOURAGE trial for acute kidney injury due to safety concerns. The company said no deaths were attributed to the study drug and no serious adverse events required expedited FDA reporting. CalciMed…
Textron posted higher fourth-quarter revenue and adjusted earnings, driven by recovering aircraft production and robust demand for aftermarket parts and services in its aviation business. The company’s 2026 profit guidance, however, came in below Wall Street expectations, prompting a pre-market share decline.
MSCI reported stronger adjusted profit for the quarter ended December 31, driven by increased client spending on its index products and analytics services. Asset-based fees rose, lifting overall revenue, while operating costs grew more modestly as the company invested in staff and technology. Management highlighted continued multi-year growth in ad…
Wix.com Ltd. shares rose sharply after the company’s board approved a $2 billion share repurchase program spanning fiscal years 2026-2027. The authorization permits purchases of ordinary shares and convertible notes via open market and private transactions, to be funded by cash on hand, operating cash flow, or potentially new capital. The program i…
